Halozyme Therapeutics Inc (STU:RV7)
€ 90.76 -0.90 (-0.98%) Market Cap: 10.26 Bil Enterprise Value: 11.91 Bil PE Ratio: 31.45 PB Ratio: 83.68 GF Score: 72/100

Halozyme Therapeutics Inc (STU:RV7) Transcripts

  • 1